Predicting mortality in children with confirmed or suspected COVID-19
A multivariate analysis
Keywords:
corona virus, children death, COVID-19Abstract
Introduction: Coronavirus disease 2019 (COVID-19) is spreading quickly and killing people across the board, including infants. The risk variables that indicate infant death are still uncertain, though. Examining risk signs for babies with COVID-19 was the aim of this study. Methods: Secondary data analysis was performed using provincial COVID-19 data from September 2021 to December 2022. For this study, 1000 children under the age of 18 were selected. In order to investigate the factors that led to fatalities in children diagnosed with COVID-19, chi-square analysis and binary logistic regression were utilized. Results: According to this research, the frequency of infants dying from COVID-19 was 6.7%. Age, case classification, therapy state, disease intensity, and trip experience all significantly correlated with toddlers infected with the COVID-19 virus’s mortality rate. Age affects the likelihood of succumbing from COVID-19 (Adjusted odd ratio (AOR) =0.92; CI 95%=0.93-0.98). In addition, using ventilators while in the ICU (AOR=22.45; 95% CI=5.86-86.33), serious sickness (AOR=46.23; 95% CI=21.33-100.63), and travel history (AOR=1.87; 95% CI=1.92-2.83) were all clearly linked to a greater chance of mortality in kids with the COVID-19. Conclusion: The greatest predictor of mortality was childhood illness that was serious.
Downloads
References
Noor, F. M., & Islam, M. M. (2020). Prevalence and associated risk factors of mortality among COVID-19 patients: a meta-analysis. Journal of community health, 45(6), 1270-1282.
Aggarwal, G., Lippi, G., & Michael Henry, B. (2020). Cerebrovascular disease is associated with an increased disease severity in patients with coronavirus disease 2019 (COVID-19): a pooled analysis of published literature. International Journal of Stroke, 15(4), 385-389.
Alsohime, F., Temsah, M. H., Al-Nemri, A. M., Somily, A. M., & Al-Subaie, S. (2020). COVID-19 infection prevalence in pediatric population: Etiology, clinical presentation, and outcome. Journal of infection and public health, 13(12), 1791-1796.
Cheng, Y., Luo, R., Wang, K., Zhang, M., Wang, Z., Dong, L., ... & Xu, G. (2020). Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney international, 97(5), 829-838.
Children and COVID-19: State-Level Data Report. American Academy of Pediatrics. Services.aap.org/en/pages/2019-novelcoronavirus-covid-19-infections/children-and-covid-19-state-leveldata-report. Accessed 19 Jan 2021
Moreira, A., Chorath, K., Rajasekaran, K., Burmeister, F., Ahmed, M., & Moreira, A. (2021). Demographic predictors of hospitalization and mortality in US children with COVID-19. European Journal of Pediatrics, 180, 1659-1663.
De Rose, D. U., Piersigilli, F., Ronchetti, M. P., Santisi, A., Bersani, I., Dotta, A., ... & Auriti, C. (2020). Novel Coronavirus disease (COVID-19) in newborns and infants: what we know so far. Italian journal of pediatrics, 46(1), 1-8.
Dewi, R., Kaswandani, N., Karyanti, M. R., Setyanto, D. B., Pudjiadi, A. H., Hendarto, A., ... & Putri, N. D. (2021). Mortality in children with positive SARS-CoV-2 polymerase chain reaction test: Lessons learned from a tertiary referral hospital in Indonesia. International Journal of Infectious Diseases, 107, 78-85.
Dhochak, N., Singhal, T., Kabra, S. K., & Lodha, R. (2020). Pathophysiology of COVID-19: why children fare better than adults?. The Indian Journal of Pediatrics, 87, 537-546.
Ding, Y. (2020). Yan Hand Guo W. Clinical characteristics of children with COVID-19: a meta-analysis. Front Pediatr, 8, 431.
Dong, Y., Mo, X., Hu, Y., Qi, X., Jiang, F., Jiang, Z., & Tong, S. (2020). Epidemiology of COVID-19 among children in China. Pediatrics, 145(6).
Wang, Y., Zhu, F., Wang, C., Wu, J., Liu, J., Chen, X., ... & Sun, D. (2020). Children hospitalized with severe COVID-19 in Wuhan. The Pediatric infectious disease journal, 39(7), e91-e94.
Götzinger, F., Santiago-García, B., Noguera-Julián, A., Lanaspa, M., Lancella, L., Carducci, F. I. C., ... & Riordan, A. (2020). COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study. The Lancet Child & Adolescent Health, 4(9), 653-661.
Hoang, A., Chorath, K., Moreira, A., Evans, M., Burmeister-Morton, F., Burmeister, F., ... & Moreira, A. (2020). COVID-19 in 7780 pediatric patients: a systematic review. EClinicalMedicine, 24, 100433.
Yang, X., Yu, Y., Xu, J., Shu, H., Liu, H., Wu, Y., ... & Shang, Y. (2020). Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. The lancet respiratory medicine, 8(5), 475-481.
Kang, S. J., & Jung, S. I. (2020). Age-related morbidity and mortality among patients with COVID-19. Infection & chemotherapy, 52(2), 154.
Kemenkes, R. I. (2020). Hindari lansia dari COVID-19. Jakarta: Kemenkes RI.
Kemenkes, R. I. (2020). Pedoman dan Pencegahan coronavirus (COVID-19). KEMENTRIAN KESEHATAN REPUBLIK INDONESIA, 1-214.
Kepmenkes RI. Decree of the minister of health of the republic of Indonesia number HK.01.07/Menkes/5671/2021 concerning clinical management of corona virus disease 2019 (Covid-19) in Health Service Facilities (Keputusan Menteri Kesehatan Republik Indonesia Nomor HK. Tentang Managemen Klinis COVID-19 di Fasilitas Layanan Kesehatan; 2021
Khan, A. A., AlRuthia, Y., Balkhi, B., Alghadeer, S. M., Temsah, M. H., Althunayyan, S. M., & Alsofayan, Y. M. (2020). Survival and estimation of direct medical costs of hospitalized COVID-19 patients in the Kingdom of Saudi Arabia. International journal of environmental research and public health, 17(20), 7458.
Kim W, Han JM, Lee KE. Predictors of mortality in patients with COVID-19: a systematic review and meta-analysis. Korean J Clin Pharm. 2020;30(3):169–176. doi:10.24304/kjcp.2020.30.3.169
Leoni, M. L. G., Lombardelli, L., Colombi, D., Bignami, E. G., Pergolotti, B., Repetti, F., ... & Nolli, M. (2021). Prediction of 28-day mortality in critically ill patients with COVID-19: Development and internal validation of a clinical prediction model. Plos one, 16(7), e0254550.
Lippi, G., & Henry, B. M. (2020). Chronic obstructive pulmonary disease is associated with severe coronavirus disease 2019 (COVID-19). Respiratory medicine, 167, 105941.
Lippi, G., Wong, J., & Henry, B. M. (2020). Hypertension and its severity or mortality in Coronavirus Disease 2019 (COVID-19): a pooled analysis. Pol Arch Intern Med, 130(4), 304-309.
Lodigiani, C., Iapichino, G., Carenzo, L., Cecconi, M., Ferrazzi, P., Sebastian, T., ... & Force, T. (2020). Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy. Thrombosis research, 191, 9-14.
Lymperopoulos, I. N. (2021). # stayhome to contain Covid-19: Neuro-SIR–Neurodynamical epidemic modeling of infection patterns in social networks. Expert Systems with Applications, 165, 113970.
Ma, H., Hu, J., Tian, J., Zhou, X., Li, H., Laws, M. T., ... & Shao, J. (2020). A single-center, retrospective study of COVID-19 features in children: a descriptive investigation. BMC medicine, 18(1), 1-11.
Means, C. (2020). Mechanisms of increased morbidity and mortality of SARS-CoV-2 infection in individuals with diabetes: what this means for an effective management strategy. Metabolism-Clinical and Experimental, 108.
Mehra, M. R., Desai, S. S., Kuy, S., Henry, T. D., & Patel, A. N. (2020). Cardiovascular disease, drug therapy, and mortality in Covid-19. New England Journal of Medicine, 382(25), e102.
Nouvellet, P., Bhatia, S., Cori, A., Ainslie, K. E. C., Baguelin, M., Bhatt, S., ... & Donnelly, C. A. Reduction in mobility and COVID-19 transmission. Nat Commun. 2021; 12 (1): 1090.
Odd, D., Stoianova, S., Williams, T., Fleming, P., & Luyt, K. (2022). Child mortality in England during the first year of the COVID-19 pandemic. Archives of disease in childhood, 107(3), e22-e22.
Parcha, V., Booker, K. S., Kalra, R., Kuranz, S., Berra, L., Arora, G., & Arora, P. (2021). A retrospective cohort study of 12,306 pediatric COVID-19 patients in the United States. Scientific reports, 11(1), 10231.
Prescott, H. C., & Girard, T. D. (2020). Recovery from severe COVID-19: leveraging the lessons of survival from sepsis. Jama, 324(8), 739-740.
Ruan, Q., Yang, K., Wang, W., Jiang, L., & Song, J. (2020). Correction to: Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive care medicine, 46(6), 1294.
Saleem, H., Rahman, J., Aslam, N., Murtazaliev, S., & Khan, S. (2020). Coronavirus disease 2019 (COVID-19) in children: vulnerable or spared? A systematic review. Cureus, 12(5).
Shekerdemian LS, Mahmood NR, Wolfe KK, et al. Characteristics and outcomes of children with coronavirus disease 2019 (COVID-19) infection admitted to US and Canadian pediatric intensive care units. JAMA Pediatr. 2020;174(9):868–873. doi:10.1001/jamapediatrics.2020.1948
Siegel, R. M., & Mallow, P. J. (2021). The impact of COVID-19 on vulnerable populations and implications for children and health care policy. Clinical Pediatrics, 60(2), 93-98.
Assembly, W. G. (2013). WMA Declaration of Helsinki—Ethical principles for medical research involving human subjects. JAMA, 310, 2191-2194.
World Health Organization. (2020). Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected. Interim guidance. Paediatrics and Family Medicine, 16(1), 9.
World Health Organization. (2020). World Health Organization coronavirus disease (COVID-19) dashboard. World Health Organization.
World Health Organization. (2021). Coronavirus Disease (COVID-19)—World Health Organization. Geneva, Switzerland.
World Health Organization. COVID-19 disease in children and adolescents. World Health Organization; 2021:1–10.
Ghebreyesus, T. A. (2020). World Health Organization. WHO Director-General’s opening remarks at the media briefing on COVID-19-25 May 2020.
Xu, Z., Shi, L., Wang, Y., Zhang, J., Huang, L., Zhang, C., ... & Wang, F. S. (2020). Pathological findings of COVID-19 associated with acute respiratory distress syndrome. The Lancet respiratory medicine, 8(4), 420-422.
Zhang, W., & Wang, H. (2014). Bin. Zhang, Y., Lu, X., Chen, LL, & Yang, L, 134-147.
Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062. doi:10.1016/S0140-6736(20)30566-3
Published
How to Cite
Issue
Section
Copyright (c) 2023 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
